Literature DB >> 26937031

Coordinated Neutralization and Immune Activation by the Cytosolic Antibody Receptor TRIM21.

Adam J Fletcher1, Leo C James2.   

Abstract

TRIM21 is a high-affinity antibody receptor uniquely expressed in the cytosol of mammalian cells. Here we summarize its role in extending antibody protection into the intracellular environment and allowing nonprofessional cells to benefit from adaptive immunity. We highlight recent work that has shed light on how TRIM21 acts as both an immune sensor and effector. We also review how TRIM21 synergizes with other innate immune receptors to promote an integrated antiviral response.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26937031      PMCID: PMC4859718          DOI: 10.1128/JVI.00050-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Protein-protein interactions between native Ro52 and immunoglobulin G heavy chain.

Authors:  Y Yang; T Eversole; D J Lee; R D Sontheimer; J D Capra
Journal:  Scand J Immunol       Date:  1999-06       Impact factor: 3.487

2.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

4.  AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.

Authors:  Felix Hauler; Donna L Mallery; William A McEwan; Susanna R Bidgood; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

5.  Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.

Authors:  P J Klasse
Journal:  Adv Biol       Date:  2014-09-09

6.  Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism.

Authors:  Wenchun Fan; Dong Zhang; Ping Qian; Suhong Qian; Mengge Wu; Huanchun Chen; Xiangmin Li
Journal:  Antiviral Res       Date:  2016-01-14       Impact factor: 5.970

7.  TRIM5α requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription.

Authors:  Adam J Fletcher; Devin E Christensen; Chad Nelson; Choon Ping Tan; Torsten Schaller; Paul J Lehner; Wesley I Sundquist; Greg J Towers
Journal:  EMBO J       Date:  2015-06-22       Impact factor: 11.598

8.  Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21.

Authors:  Adam J Fletcher; Donna L Mallery; Ruth E Watkinson; Claire F Dickson; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

9.  Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells.

Authors:  Susanna R Bidgood; Jerry C H Tam; William A McEwan; Donna L Mallery; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-28       Impact factor: 11.205

10.  TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus.

Authors:  Ruth E Watkinson; William A McEwan; Jerry C H Tam; Marina Vaysburd; Leo C James
Journal:  PLoS Pathog       Date:  2015-10-27       Impact factor: 6.823

View more
  16 in total

Review 1.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

2.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

3.  Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet's disease.

Authors:  Yuri Ahn; Ji-Hye Hwang; Zhenlong Zheng; Dongsik Bang; Do-Young Kim
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

4.  Autoantibodies against the Immunoglobulin-Binding Region of Ro52 Link its Autoantigenicity with Pathogen Neutralization.

Authors:  Peter D Burbelo; Leyla Y Teos; Jesse L Herche; Michael J Iadarola; Ilias Alevizos
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.996

Review 5.  RING-Domain E3 Ligase-Mediated Host-Virus Interactions: Orchestrating Immune Responses by the Host and Antagonizing Immune Defense by Viruses.

Authors:  Yuexiu Zhang; Lian-Feng Li; Muhammad Munir; Hua-Ji Qiu
Journal:  Front Immunol       Date:  2018-05-22       Impact factor: 7.561

6.  Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21.

Authors:  Claire Dickson; Adam J Fletcher; Marina Vaysburd; Ji-Chun Yang; Donna L Mallery; Jingwei Zeng; Christopher M Johnson; Stephen H McLaughlin; Mark Skehel; Sarah Maslen; James Cruickshank; Nicolas Huguenin-Dezot; Jason W Chin; David Neuhaus; Leo C James
Journal:  Elife       Date:  2018-04-18       Impact factor: 8.140

7.  Prior immune exposure can protect or can enhance pathology in the enteroviruses: what predicts the outcome?

Authors:  Nora M Chapman
Journal:  Virulence       Date:  2016-12-09       Impact factor: 5.882

Review 8.  TRIM21-From Intracellular Immunity to Therapy.

Authors:  Stian Foss; Maria Bottermann; Alexandra Jonsson; Inger Sandlie; Leo C James; Jan Terje Andersen
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

9.  TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination.

Authors:  Maria Bottermann; Stian Foss; Laurens M van Tienen; Marina Vaysburd; James Cruickshank; Kevin O'Connell; Jessica Clark; Keith Mayes; Katie Higginson; Jack C Hirst; Martin B McAdam; Greg Slodkowicz; Edward Hutchinson; Patrycja Kozik; Jan Terje Andersen; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-12       Impact factor: 11.205

Review 10.  Intracellular Antiviral Immunity.

Authors:  Maria Bottermann; Leo C James
Journal:  Adv Virus Res       Date:  2018-02-16       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.